Standardized Escin
Global Export Markets
Traceable Batch Control
Certified Facility
The global demand for Aesculus Hippocastanum (Horse Chestnut) Seed Extract is experiencing an unprecedented surge, driven by consumer transition toward clinically-backed, botanical alternatives. In the pharmaceutical and personal care landscapes, formulation integrity is paramount. Raw ingredient inconsistency can compromise therapeutic efficacy, leading to unstable viscosity, failed bio-activity, or regulatory challenges.
Andy Biotech addresses these market pain points by delivering high-stability, standardized Aesculus Hippocastanum Seed Extract solutions optimized for both topical and oral modalities. By eliminating variability in saponin density, our extract guarantees uniform performance in multi-ingredient systems, preventing coagulation, sedimentation, or degradation over time.
The commercialization of Aesculus Hippocastanum Seed Extract operates within a highly regulated international framework. As key exporters, we observe shifting procurement patterns: North American and European buyers demand low-esculin profiles to prevent toxicity, while APAC manufacturers prioritize water solubility for cosmetic integration.
Stricter compliance criteria by the European Medicines Agency (EMA) and US FDA demand extensive validation of active components and contaminant thresholds, making documented validation critical for imports.
Raw plant powders are no longer viable for high-tier products. The industry standard requires precise Escin profiles (typically 20% by HPLC/UV-Vis) to ensure repeatable batch efficacy.
Conscious consumers demand ethical wild-harvesting and processing. Green extraction methodologies and eco-responsible logistics are now basic requirements rather than premium options.
Andy Biotech: Your Trusted Partner in Plant Extract Solutions
Andy Biotech is a leading manufacturer and supplier of premium-quality, scientifically-validated plant extracts for the food, beverage, nutraceutical, cosmetic, and pharmaceutical industries. Founded on a commitment to purity, potency, and innovation, we bridge the gap between nature’s potential and your product development goals.
Our core strength lies in our vertically integrated process, which gives us complete control from seed to extract. We partner with a network of certified organic and sustainably managed farms to ensure the integrity of every raw material. Our state-of-the-art extraction facilities employ advanced technologies, including supercritical solvent and water-based methods, to preserve the full spectrum of bioactive compounds without compromising on environmental responsibility.
We execute rigorous control measures at every critical processing juncture to ensure our ingredients exceed global regulatory expectations.
To assist procurement and analytical chemists, the validation of Aesculus Hippocastanum Seed Extract must be structured on reliable HPLC fingerprints. Below is the specification benchmark for Andy Biotech’s wholesale export grade:
| Analytical Parameter | Specification Target | Methodology / Standard |
|---|---|---|
| Assay (Escin Content) | ≥ 20.0% (anhydrous basis) | UV-Vis / HPLC (Ph. Eur. Reference) | Appearance | Fine Light Yellow-Brown Powder | Organoleptic |
| Loss on Drying | ≤ 5.0% | USP <731> (105°C, 3 Hours) |
| Heavy Metals (Pb, As, Hg, Cd) | ≤ 10.0 ppm (Pb ≤ 2.0 ppm) | ICP-MS (USP <233>) |
| Pesticide Residues | Complies with EC No 396/2005 | GC-MS / LC-MS-MS |
| Residual Solvents | Ethanol only (≤ 5000 ppm) | GC-Headspace |
| Esculin / Esculoside Limit | ≤ 0.1% (Toxicity threshold control) | Thin-Layer Chromatography (TLC) |
Andy was born in a small village close to the Hanjiang River in Hanzhong, Shaanxi province, China. Thirty years ago, when she was still a little child, she caught a cold, but medical services were not available unless the family crossed over high mountains to find a hospital. Thus, Andy's grandfather first used Echinacea leaves soaked in water for her treatment, then he dug Echinacea root, shredded it into pulp, and squeezed the liquid for Andy to drink one spoon every two hours. Andy recovered after this treatment.
As a child, Andy watched her grandfather harness the healing power of plants in his humble garden. His ancient herbal remedies were not just treatments; they were magic. That early wonder blossomed into a profound passion for plant extracts and a deep respect for nature’s wisdom. From that time on, little Andy swore that she would help to spread herbs all over the world to benefit more people.
This personal journey is the heart of Andy Biotech. It’s why Andy Biotech is dedicated to researching and delivering the purest, most effective botanical solutions for modern wellness. Andy’s lifelong vow is to honor that tradition by innovating for a healthier future, empowering lives through the timeless power of plants.
Aesculus Hippocastanum Seed Extract is highly versatile, but its chemistry behaves differently depending on the matrix environment. Our application team helps developers navigate localized demands:
Objective: Anti-redness, microcirculation stimulation, and soothing swollen skin.
Formulation Key: High-clarity, water-soluble, decolorized Escin grades. Perfect for under-eye creams, leg soothing gels, and rosacea-prone skin formulations.
Objective: Vein support, vascular integrity, and lymphatic drainage.
Formulation Key: Standardized Escin 20% powder, compatible with hard gelatin capsules, tablets, and liquid elixirs. Fits clean-label requirements.
Objective: Accelerating bruise recovery and soothing muscle strain swelling.
Formulation Key: Highly bioavailable topical emulsions combined with menthol or arnica, ensuring transdermal absorption.
Exporting botanical APIs requires navigating complex regulatory standards. Andy Biotech simplifies this through a dedicated compliance and localization framework:
We support global manufacturers with custom clearance paperwork, local regulatory dossier preparation, and warehousing setups that guarantee continuous ingredient availability. This reduces the risk of supply chain interruptions.
The botanical extraction industry is shifting toward greener, more targeted methods. Our R&D team is focused on several upcoming developments:
Transitioning from traditional solvents to subcritical water extraction systems. This process yields clean extracts with fewer environmental residues.
Partnering with cosmetic labs to develop lipid-encapsulated Escin. This enhancement aims to improve transdermal delivery through the stratum corneum.
Expanding our organic sourcing partnerships to guarantee secure harvests, shielding buyers from raw material cost fluctuations.
Andy Biotech
